Related Experiment Video
Updated: Apr 27, 2026

10:36
High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning
Published on: December 15, 2016
12.2K
Targeting synaptic pathology with a novel affinity mass spectrometry approach
Ann Brinkmalm1, Gunnar Brinkmalm2, William G Honer3
1From the ‡Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, S43180 Mölndal, Sweden; ann.brinkmalm@neuro.gu.se.
Molecular & Cellular Proteomics : MCP
|June 29, 2014
Summary
Researchers developed a new method to measure synaptic proteins in brain tissue. This technique revealed changes in presynaptic proteins in Alzheimer's disease and prion infections.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Synaptic pathology is a key feature of neurodegenerative diseases.
- Studying the SNARE (soluble NSF attachment protein receptor) complex is crucial for understanding synaptic function and dysfunction.
- Existing methods for analyzing synaptic proteins can be limited in scope or throughput.
Purpose of the Study:
- To develop and validate a novel, high-throughput strategy for concurrently measuring multiple SNARE complex proteins in individual brain tissue samples.
- To apply this method to investigate alterations in synaptic protein levels in disease states.
Main Methods:
- The study employed a combination of affinity purification and mass spectrometry.
- This technique allows for the simultaneous quantification of four specific SNARE complex proteins.
- The method was validated for use across different species and adaptable for other neuronal targets.
Main Results:
- The novel method successfully measured levels of four SNARE complex proteins in individual brain samples.
- Significantly altered levels of specific presynaptic proteins were identified in brain tissue from Alzheimer disease patients.
- Similar alterations in presynaptic protein levels were observed in a mouse model of prion disease.
Conclusions:
- The developed affinity purification and mass spectrometry method provides a powerful tool for studying synaptic pathology.
- This approach reveals distinct changes in presynaptic protein composition associated with Alzheimer disease and prion infections.
- The technique holds promise for broader applications in neuroscience research and biomarker discovery.

